Javelin Biotech Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
7
Javelin Biotech General Information
Description
Operator of a predictive drug discovery platform intended to make an enhanced prediction of the performance of drugs in humans. The company's platform brings the human-relevant in-vitro data and computational biology or data analytics to pre-clinical drug discovery teams by accelerating preclinical drug discovery and development by finding human-relevant targets, enabling biopharmaceutical companies to optimize ADME(T) and PD properties which improves drug discovery and approval of the same.
Contact Information
Website
www.javelinbiotech.comCorporate Office
- 900 Middlesex Turnpike
- Building 5
- Billerica, MA 01801
- United States
Corporate Office
- 900 Middlesex Turnpike
- Building 5
- Billerica, MA 01801
- United States
Javelin Biotech Timeline
Javelin Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 7. Grant | 30-Aug-2023 | Completed | Generating Revenue | |||
| 6. Grant | 18-Aug-2022 | Completed | Generating Revenue | |||
| 5. Grant | 21-Sep-2021 | Completed | Generating Revenue | |||
| 4. Seed Round | 03-Sep-2019 | Completed | Generating Revenue | |||
| 3. Grant | 05-Aug-2019 | Completed | Generating Revenue | |||
| 2. Grant | 18-Sep-2018 | $1.44M | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 01-Jan-2018 | Completed | Generating Revenue |
Javelin Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Javelin Biotech Patents
Javelin Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250122456-A1 | Micro-physiological platform for immune response modeling | Pending | 25-Sep-2023 | ||
| WO-2025072332-A1 | Micro-physiological platform for immune response modeling | Inactive | 25-Sep-2023 | ||
| US-20240228927-A1 | Microfluidic platform for detection of liver injury | Pending | 05-Jan-2023 | ||
| WO-2024148297-A1 | Microfluidic platform for detection of liver injury | Inactive | 05-Jan-2023 | ||
| US-20240150696-A1 | Tapping device for microfluidic system | Pending | 07-Nov-2022 | C12M23/16 |
Javelin Biotech Signals
Javelin Biotech Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| C2I Accelerator | Accelerator/Incubator | |||
| National Institutes of Health | Government | |||
| Innospark Ventures | Venture Capital | Minority | ||
| Joyance Partners | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Javelin Biotech FAQs
-
When was Javelin Biotech founded?
Javelin Biotech was founded in 2018.
-
Where is Javelin Biotech headquartered?
Javelin Biotech is headquartered in Billerica, MA.
-
What is the size of Javelin Biotech?
Javelin Biotech has 9 total employees.
-
What industry is Javelin Biotech in?
Javelin Biotech’s primary industry is Discovery Tools (Healthcare).
-
Is Javelin Biotech a private or public company?
Javelin Biotech is a Private company.
-
What is Javelin Biotech’s current revenue?
The current revenue for Javelin Biotech is .
-
How much funding has Javelin Biotech raised over time?
Javelin Biotech has raised $1M.
-
Who are Javelin Biotech’s investors?
C2I Accelerator, National Institutes of Health, Innospark Ventures, Joyance Partners, and are 5 of 7 investors who have invested in Javelin Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process